<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ferrandez MC</submitter><funding>Hanarth Fonds</funding><funding>KWF Kankerbestrijding</funding><pagination>140</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12662970</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The aim of this study was to develop 3D convolutional neural networks (CNN) for the prediction of 2 years' time to progression using PET/CT baseline scans from diffuse large B-cell lymphoma (DLBCL) patients. The predictive performance of the 3D CNNs was compared to that of the International Prognostic Index (IPI) and a previously developed 2D CNN model using maximum intensity projections (MIP-CNN).&lt;h4>Results&lt;/h4>1132 DLBCL patients were included from 7 independent clinical trials. Two 3D CNN models were developed using a training dataset of 636 patient scans merged from two trials, one CNN model trained on lesion-only PET (L-PET3D-CNN) and the second model trained on both lesion-only and whole body PET scans (LW-PET3D-CNN). The 3D models were cross-validated and perform</pubmed_abstract><journal>EJNMMI research</journal><pubmed_title>Predicting 2-year time to progression in diffuse large B cell lymphoma using 3D CNNs on whole-body PET/CT scans.</pubmed_title><pmcid>PMC12662970</pmcid><funding_grant_id>#VU-2018-11648</funding_grant_id><funding_grant_id>Hanarth Fonds</funding_grant_id><pubmed_authors>Mikhaeel NG</pubmed_authors><pubmed_authors>Gyorke T</pubmed_authors><pubmed_authors>Czibor S</pubmed_authors><pubmed_authors>Eertink JJ</pubmed_authors><pubmed_authors>Zijlstra JM</pubmed_authors><pubmed_authors>Ferrandez MC</pubmed_authors><pubmed_authors>Zwezerijnen GJC</pubmed_authors><pubmed_authors>Hanoun C</pubmed_authors><pubmed_authors>Lugtenburg PJ</pubmed_authors><pubmed_authors>Ceriani L</pubmed_authors><pubmed_authors>Zucca E</pubmed_authors><pubmed_authors>Heymans MW</pubmed_authors><pubmed_authors>Wiegers SE</pubmed_authors><pubmed_authors>Kurch L</pubmed_authors><pubmed_authors>Huttmann A</pubmed_authors><pubmed_authors>Chamuleau MED</pubmed_authors><pubmed_authors>Barrington SF</pubmed_authors><pubmed_authors>Boellaard R</pubmed_authors><pubmed_authors>Duhrsen U</pubmed_authors><pubmed_authors>Golla SSV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predicting 2-year time to progression in diffuse large B cell lymphoma using 3D CNNs on whole-body PET/CT scans.</name><description>&lt;h4>Background&lt;/h4>The aim of this study was to develop 3D convolutional neural networks (CNN) for the prediction of 2 years' time to progression using PET/CT baseline scans from diffuse large B-cell lymphoma (DLBCL) patients. The predictive performance of the 3D CNNs was compared to that of the International Prognostic Index (IPI) and a previously developed 2D CNN model using maximum intensity projections (MIP-CNN).&lt;h4>Results&lt;/h4>1132 DLBCL patients were included from 7 independent clinical trials. Two 3D CNN models were developed using a training dataset of 636 patient scans merged from two trials, one CNN model trained on lesion-only PET (L-PET3D-CNN) and the second model trained on both lesion-only and whole body PET scans (LW-PET3D-CNN). The 3D models were cross-validated and perform</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T21:35:31.101Z</modification><creation>2026-05-22T03:12:32.872Z</creation></dates><accession>S-EPMC12662970</accession><cross_references><pubmed>41313405</pubmed><doi>10.1186/s13550-025-01336-1</doi></cross_references></HashMap>